• Cat-intel
  • MedIntelliX
  • Resources
  • About Us
  • Request Free Sample ×

    Kindly complete the form below to receive a free sample of this Report

    Leading companies partner with us for data-driven Insights

    clients tt-cursor
    Hero Background

    APAC Pharmaceutical Glass Packaging Market

    ID: MRFR/PNT/20060-HCR
    128 Pages
    Snehal Singh
    October 2025

    Asia Pacific Pharmaceutical Glass Packaging Market Research Report Information By Product (Vials & Ampoules, Cartridges, Bottles, and Syringes), By Drug Type (Generic, Branded and Biologic) –and Asia Pacific Market Forecast Till 2035

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    APAC Pharmaceutical Glass Packaging Market Infographic
    Purchase Options

    APAC Pharmaceutical Glass Packaging Market Summary

    As per MRFR analysis, the Asia Pacific Pharmaceutical Glass Packaging Market was estimated at 19.96 USD Billion in 2024. The market is projected to grow from 21.4 USD Billion in 2025 to 42.89 USD Billion by 2035, exhibiting a compound annual growth rate (CAGR) of 7.2 during the forecast period 2025 - 2035.

    Key Market Trends & Highlights

    The Asia Pacific Pharmaceutical Glass Packaging Market is poised for substantial growth driven by sustainability and technological advancements.

    • Sustainability initiatives are increasingly shaping packaging strategies across the Asia Pacific region.
    • Technological advancements in glass manufacturing are enhancing product quality and efficiency, particularly in North America.
    • Customization and design trends are gaining traction, especially in the vials and ampoules segment, which remains the largest.
    • The rising demand for biopharmaceuticals and increased focus on sustainable packaging solutions are key drivers propelling market growth.

    Market Size & Forecast

    2024 Market Size 19.96 (USD Billion)
    2035 Market Size 42.89 (USD Billion)
    CAGR (2025 - 2035) 7.2%

    Major Players

    Schott AG (DE), Gerresheimer AG (DE), Nipro Corporation (JP), Owen Mumford Limited (GB), Ardagh Group (IE), Amcor plc (AU), Corning Incorporated (US), SGB Packaging (IN), Hindusthan National Glass & Industries Limited (IN)

    APAC Pharmaceutical Glass Packaging Market Trends

    The Asia Pacific Pharmaceutical Glass Packaging Market is currently experiencing a transformative phase, driven by a confluence of factors that include increasing demand for high-quality packaging solutions and a growing emphasis on sustainability. As pharmaceutical companies strive to enhance product safety and efficacy, glass packaging emerges as a preferred choice due to its inert nature and ability to preserve the integrity of sensitive medications. Furthermore, the region's expanding healthcare sector, coupled with rising investments in research and development, appears to bolster the market's growth trajectory. This evolving landscape suggests a shift towards innovative packaging designs that cater to both functional and aesthetic requirements, thereby enhancing user experience. In addition, the Asia Pacific Pharmaceutical Glass Packaging Market is likely to witness a surge in the adoption of eco-friendly materials and practices. Regulatory frameworks are increasingly favoring sustainable packaging solutions, prompting manufacturers to explore alternatives that minimize environmental impact. This trend may lead to the development of new glass formulations and recycling initiatives aimed at reducing waste. As consumer awareness regarding environmental issues grows, the market could see a significant shift towards sustainable practices, aligning with global efforts to promote responsible consumption and production. Overall, the Asia Pacific Pharmaceutical Glass Packaging Market is poised for substantial growth, driven by innovation, sustainability, and a commitment to quality in pharmaceutical packaging.

    Sustainability Initiatives

    The Asia Pacific Pharmaceutical Glass Packaging Market is witnessing a notable shift towards sustainability. Manufacturers are increasingly adopting eco-friendly practices, such as utilizing recyclable materials and reducing carbon footprints. This trend aligns with global environmental goals and reflects a growing consumer preference for sustainable products.

    Technological Advancements

    Innovations in glass manufacturing processes are reshaping the Asia Pacific Pharmaceutical Glass Packaging Market. Advanced technologies are enhancing the durability and functionality of glass containers, making them more appealing to pharmaceutical companies. These advancements may lead to improved product safety and extended shelf life.

    Customization and Design Trends

    There is a rising demand for customized glass packaging solutions within the Asia Pacific Pharmaceutical Glass Packaging Market. Pharmaceutical companies are seeking unique designs that not only serve functional purposes but also enhance brand identity. This trend indicates a shift towards more personalized packaging options.

    APAC Pharmaceutical Glass Packaging Market Drivers

    Rising Demand for Biopharmaceuticals

    The Asia Pacific Pharmaceutical Glass Packaging Market is experiencing a notable increase in demand for biopharmaceuticals, which are often sensitive to environmental factors. This trend is driven by the growing prevalence of chronic diseases and the need for advanced therapies. Biopharmaceuticals typically require specialized packaging solutions to ensure stability and efficacy, which glass packaging provides. The market for biopharmaceuticals in the Asia Pacific region is projected to grow at a compound annual growth rate (CAGR) of approximately 8% over the next five years. This growth is likely to bolster the demand for glass packaging, as manufacturers seek reliable and safe options to protect their products.

    Regulatory Compliance and Safety Standards

    The Asia Pacific Pharmaceutical Glass Packaging Market is significantly influenced by stringent regulatory compliance and safety standards imposed by health authorities. These regulations necessitate the use of high-quality packaging materials that can withstand various environmental conditions while ensuring product integrity. Glass packaging is often favored due to its inert nature, which minimizes the risk of contamination. As regulatory bodies continue to enforce rigorous guidelines, pharmaceutical companies are increasingly turning to glass packaging solutions to meet these requirements. This trend is expected to drive market growth, as adherence to safety standards becomes paramount in the pharmaceutical sector.

    Growing Investment in Healthcare Infrastructure

    The Asia Pacific Pharmaceutical Glass Packaging Market is positively impacted by the growing investment in healthcare infrastructure across the region. Governments and private entities are increasingly allocating resources to enhance healthcare facilities, which in turn drives the demand for pharmaceutical products and their packaging. This investment is particularly evident in emerging economies, where the expansion of healthcare services is creating new opportunities for pharmaceutical companies. As the healthcare sector continues to grow, the demand for reliable and safe packaging solutions, such as glass, is expected to rise, further propelling the growth of the glass packaging market.

    Technological Innovations in Glass Manufacturing

    The Asia Pacific Pharmaceutical Glass Packaging Market is benefiting from technological innovations in glass manufacturing processes. Advances in production techniques, such as automated manufacturing and improved quality control measures, are enhancing the efficiency and reliability of glass packaging solutions. These innovations not only reduce production costs but also improve the overall quality of the packaging, making it more appealing to pharmaceutical companies. As the industry continues to evolve, the integration of smart technologies in glass production is expected to further drive market growth, as manufacturers seek to optimize their operations and meet the increasing demand for high-quality packaging.

    Increased Focus on Sustainable Packaging Solutions

    The Asia Pacific Pharmaceutical Glass Packaging Market is witnessing a shift towards sustainable packaging solutions, driven by both consumer preferences and regulatory pressures. Glass is inherently recyclable and can be reused, making it an attractive option for environmentally conscious companies. The demand for sustainable practices is reflected in the increasing number of pharmaceutical companies committing to reduce their carbon footprint. According to recent estimates, the sustainable packaging market in the Asia Pacific region is expected to grow by over 10% annually. This trend is likely to enhance the appeal of glass packaging, as it aligns with the broader movement towards sustainability in the pharmaceutical industry.

    Market Segment Insights

    By Product: Vials & Ampoules (Largest) vs. Syringes (Fastest-Growing)

    In the Asia Pacific Pharmaceutical Glass Packaging Market, vials and ampoules lead as the largest segment, effectively catering to the growing demand for injectable pharmaceuticals. Their unique design and ability to maintain sterility make them a preferred choice for various drugs. Bottles and cartridges also hold significant shares, but they are trailing behind the dominance of vials and ampoules. Syringes, on the other hand, are emerging rapidly due to the increasing prevalence of self-administration therapies and biological drugs that require precise dosing, further supporting their growth in this sector.

    Vials & Ampoules (Dominant) vs. Syringes (Emerging)

    Vials and ampoules have long been regarded as the dominant forms of pharmaceutical glass packaging, offering superior containment and protection from environmental factors. Their widespread applications in vaccines and injectable medications underscore their importance in the industry. The shift toward biologics and personalized medicine has amplified their relevance. Meanwhile, syringes are quickly evolving as an emerging segment, particularly in response to the rise in diabetes and other chronic conditions requiring self-injection. Innovations in syringe design, such as pre-filled and safety syringes, are enhancing user convenience and safety, targeting not just hospitals but also homecare settings. This combination of growing demand and innovation is fuelling the rapid upward trajectory of syringes in the market.

    By Drug Type: Generic (Largest) vs. Biologic (Fastest-Growing)

    In the Asia Pacific Pharmaceutical Glass Packaging Market, the Drug Type segment comprises three primary categories: Generic, Branded, and Biologic. Currently, Generic drugs dominate the market due to their wide acceptance and affordability, allowing them to capture a substantial share of the overall packaging requirements. Branded drugs, while significant, follow the generic segment but benefit from heightened brand loyalty and specific therapeutic applications. Biologics, representing the emerging field, are gaining traction quickly as more complex therapies require specialized glass packaging solutions.

    Generic (Dominant) vs. Biologic (Emerging)

    Generic drugs hold a dominant position in the Asia Pacific Pharmaceutical Glass Packaging Market, characterized by their cost-effectiveness and extensive utilization in various therapeutic areas. This segment benefits from the increasing demand for affordable medication options across the region, driving manufacturers to adopt resilient and reliable packaging solutions. In contrast, biologics are emerging rapidly, fueled by advancements in biotechnology and the growing prevalence of chronic diseases. Although still in the early stages compared to generics, biologics require specialized glass packaging due to their complex compositions, which necessitates the design of innovative and safe packaging formats.

    Get more detailed insights about APAC Pharmaceutical Glass Packaging Market

    Regional Insights

    North America : Pharmaceutical Innovation Hub

    The North American pharmaceutical glass packaging market is driven by increasing demand for high-quality packaging solutions, particularly in the biopharmaceutical sector. The U.S. holds the largest market share at approximately 70%, followed by Canada at around 15%. Regulatory support for stringent quality standards and safety measures further catalyzes market growth. The region's focus on innovation and sustainability is also shaping demand trends, with a shift towards eco-friendly materials. Leading countries in this region include the United States and Canada, with major players like Corning Incorporated and Schott AG dominating the landscape. The competitive environment is characterized by continuous advancements in technology and product offerings. Companies are investing in R&D to enhance product performance and meet evolving regulatory requirements. This competitive edge is crucial for maintaining market leadership in a rapidly changing industry.

    Europe : Regulatory Compliance Focus

    The European pharmaceutical glass packaging market is characterized by stringent regulatory frameworks and a strong emphasis on sustainability. Germany and France are the largest markets, holding approximately 30% and 20% market shares, respectively. The European Medicines Agency (EMA) plays a pivotal role in shaping regulations that promote safety and efficacy in pharmaceutical packaging, driving demand for high-quality glass solutions. The region is witnessing a shift towards eco-friendly packaging materials, aligning with broader environmental goals. Key players in Europe include Gerresheimer AG and Schott AG, which are at the forefront of innovation in glass packaging. The competitive landscape is marked by collaborations and partnerships aimed at enhancing product offerings and meeting regulatory standards. Countries like Italy and the UK are also significant contributors to market growth, with a focus on advanced manufacturing techniques and sustainable practices. This dynamic environment fosters a robust market for pharmaceutical glass packaging.

    Asia-Pacific : Emerging Market Potential

    The Asia-Pacific pharmaceutical glass packaging market is experiencing rapid growth, driven by increasing healthcare expenditures and a rising demand for biologics. China and India are the largest markets, accounting for approximately 40% and 25% of the market share, respectively. The region's expanding pharmaceutical industry, coupled with supportive government policies, is propelling demand for high-quality glass packaging solutions. Regulatory frameworks are evolving to ensure compliance with international standards, further enhancing market prospects. Leading countries in this region include Japan, Australia, and South Korea, with key players such as Nipro Corporation and Amcor plc making significant contributions. The competitive landscape is characterized by a mix of local and international companies, fostering innovation and technological advancements. As the region continues to grow, the focus on quality and sustainability in packaging solutions is becoming increasingly important, positioning Asia-Pacific as a vital market for pharmaceutical glass packaging.

    Middle East and Africa : Resource-Rich Market Dynamics

    The Middle East and Africa pharmaceutical glass packaging market is gradually expanding, driven by increasing healthcare investments and a growing pharmaceutical sector. The UAE and South Africa are the largest markets, holding approximately 30% and 20% market shares, respectively. The region's diverse healthcare needs and regulatory developments are fostering demand for high-quality glass packaging solutions. Government initiatives aimed at improving healthcare infrastructure are also contributing to market growth. Key players in this region include Hindusthan National Glass & Industries Limited and SGB Packaging, which are focusing on enhancing product quality and expanding their market presence. The competitive landscape is evolving, with both local and international companies vying for market share. As the region continues to develop, the emphasis on quality and compliance with international standards is becoming increasingly critical for success in the pharmaceutical glass packaging market.

    Key Players and Competitive Insights

    The Asia Pacific Pharmaceutical Glass Packaging Market is currently characterized by a dynamic competitive landscape, driven by increasing demand for high-quality packaging solutions that ensure product integrity and safety. Key players such as Schott AG (Germany), Gerresheimer AG (Germany), and Nipro Corporation (Japan) are strategically positioned to leverage innovation and regional expansion to enhance their market presence. Schott AG (Germany) focuses on advanced glass technologies, while Gerresheimer AG (Germany) emphasizes sustainable packaging solutions. Nipro Corporation (Japan) is enhancing its operational capabilities through digital transformation initiatives, collectively shaping a competitive environment that prioritizes quality and sustainability.

    The market structure appears moderately fragmented, with several players vying for market share through localized manufacturing and supply chain optimization. This fragmentation allows for a diverse range of products and services, catering to the specific needs of pharmaceutical companies across the region. The collective influence of these key players fosters a competitive atmosphere where innovation and operational efficiency are paramount.

    In August 2025, Schott AG (Germany) announced the launch of a new line of eco-friendly glass vials designed to reduce carbon emissions during production. This strategic move not only aligns with global sustainability trends but also positions Schott as a leader in environmentally responsible packaging solutions. The introduction of these vials is likely to attract pharmaceutical companies seeking to enhance their sustainability credentials.

    In September 2025, Gerresheimer AG (Germany) expanded its manufacturing capabilities in India by opening a new facility dedicated to producing high-quality glass containers. This expansion reflects Gerresheimer's commitment to meeting the growing demand in the Asia Pacific region and underscores its strategy of localizing production to reduce lead times and improve supply chain efficiency. Such initiatives may enhance the company's competitive edge in a rapidly evolving market.

    In July 2025, Nipro Corporation (Japan) entered into a strategic partnership with a leading technology firm to integrate AI-driven solutions into its production processes. This collaboration aims to optimize manufacturing efficiency and enhance product quality, potentially setting a new standard in the pharmaceutical glass packaging sector. The integration of AI technologies could provide Nipro with a significant advantage in terms of operational excellence and responsiveness to market demands.

    As of October 2025, the competitive trends in the Asia Pacific Pharmaceutical Glass Packaging Market are increasingly defined by digitalization, sustainability, and technological integration. Strategic alliances among key players are shaping the landscape, fostering innovation and enhancing supply chain reliability. Moving forward, it appears that competitive differentiation will evolve from traditional price-based competition to a focus on innovation, technology adoption, and sustainable practices, reflecting the changing priorities of the pharmaceutical industry.

    Key Companies in the APAC Pharmaceutical Glass Packaging Market market include

    Industry Developments

    March 2021: A subsidiary of The Oneida Group, Anchor Hocking Glass Company's Monaca, Pennsylvania glass factory, was acquired by Stoelzle Glass Group. This acquisition helped the company start its seventh glass plant in the US and first outside Europe.

    In the year of 2023 when Gerresheimer AG started the cooperation with SCHOTT AG and Stevanato Group titled “Alliance for RTU” Ready-To-Use for pharmaceutical packaging. This alliance aims at enhancing efficiency of the ready-to-use/pre-sterilized packaging systems in Asia where pharmaceutical companies’ drug safety and delivery systems would be made perfect by this collaboration in the pharmaceutical sector.

    In October of the year 2023 Nippon Glass enlarged its activities in the territory of China by purchasing one of the local pharmaceutical glass packaging manufacturers. Such a step emphasizes the growing weight of the Chinese market for foreign companies as it houses a huge pharmaceutical market and a shift towards new safe packaging materials.

    According to the current estimates, as of October 2023, Gerresheimer AG, one of the leaders in the industry of pharmaceutical glass containers, managed to expand its constructor production facilities in China and reinforce its position on the fast-evolving market. Also, in Dec 2023, a Japanese company called Nipro Corporation launched the production of avant-garde glass containers for biopharmaceuticals, claiming the attention to glass packing innovation.

    Future Outlook

    APAC Pharmaceutical Glass Packaging Market Future Outlook

    The Asia Pacific Pharmaceutical Glass Packaging Market is poised for growth at a 7.2% CAGR from 2024 to 2035, driven by increasing demand for biologics and sustainable packaging solutions.

    New opportunities lie in:

    • Expansion into eco-friendly glass alternatives for pharmaceutical packaging.
    • Development of smart glass packaging with integrated tracking technology.
    • Investment in automated production lines to enhance efficiency and reduce costs.

    By 2035, the market is expected to achieve robust growth, driven by innovation and sustainability.

    Market Segmentation

    APAC Pharmaceutical Glass Packaging Market Product Outlook

    • Vials & Ampoules
    • Bottles
    • Cartridges
    • Syringes

    APAC Pharmaceutical Glass Packaging Market Drug Type Outlook

    • Generic
    • Branded
    • Biologic

    Report Scope

    MARKET SIZE 202419.96(USD Billion)
    MARKET SIZE 202521.4(USD Billion)
    MARKET SIZE 203542.89(USD Billion)
    COMPOUND ANNUAL GROWTH RATE (CAGR)7.2% (2024 - 2035)
    REPORT COVERAGERevenue Forecast, Competitive Landscape, Growth Factors, and Trends
    BASE YEAR2024
    Market Forecast Period2025 - 2035
    Historical Data2019 - 2024
    Market Forecast UnitsUSD Billion
    Key Companies ProfiledMarket analysis in progress
    Segments CoveredMarket segmentation analysis in progress
    Key Market OpportunitiesAdoption of sustainable materials and innovative designs in the Asia Pacific Pharmaceutical Glass Packaging Market.
    Key Market DynamicsRising demand for sustainable packaging solutions drives innovation in the Asia Pacific Pharmaceutical Glass Packaging Market.
    Countries CoveredNorth America, Europe, APAC, South America, MEA

    Market Highlights

    Author
    Snehal Singh
    Assistant Manager - Research

    High acumen in analyzing complex macro & micro markets with more than 6 years of work experience in the field of market research. By implementing her analytical skills in forecasting and estimation into market research reports, she has expertise in Packaging, Construction, and Equipment domains. She handles a team size of 20-25 resources and ensures smooth running of the projects, associated marketing activities, and client servicing.

    Leave a Comment

    FAQs

    How much is Pharmaceutical Glass Packaging market?

    The Asia Pacific Pharmaceutical Glass Packaging market size valued at USD 19.96 Billion in 2024.

    What is growth rate of the Pharmaceutical Glass Packaging market?

    APAC Pharmaceutical Glass Packaging Market is projected to grow at a CAGR of 7.2% during the forecast period, 2025-2035

    Who are the key players in the Pharmaceutical Glass Packaging market?

    The key players in the market are Saint-Gobain, Owens-Illinois, Inc., Amcor plc, Ardagh Group S.A., HEINZ-GLAS GmbH & Co. KGaA, BA GLASS GROUP, Bormioli Rocco S.p.A, Gerresheimer AG, Hindustan National Glass & Industries Limited. and KOA GLASS CO. LTD.

    Which product led the Pharmaceutical Glass Packaging market?

    The bottles category dominates the market in 2024.

    Which drug type held the largest market share in the Pharmaceutical Glass Packaging market?

    The generic drugs category had the largest share in the market.

    Download Free Sample

    Kindly complete the form below to receive a free sample of this Report

    Case Study
    Chemicals and Materials

    Compare Licence

    ×
    Features License Type
    Single User Multiuser License Enterprise User
    Price $4,950 $5,950 $7,250
    Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
    Free Customization
    Direct Access to Analyst
    Deliverable Format
    Platform Access
    Discount on Next Purchase 10% 15% 15%
    Printable Versions